Clinical Trials List
2023-06-30 - 2030-12-31
Phase III
Recruiting7
ICD-10N05.9
Unspecified nephritic syndrome with unspecified morphologic changes
ICD-9583.0
Nephritis and nephropathy, not specified as acute or chronic, with lesion of proliferative glomerulonephritis
xxxxxx
-
Sponsor
xxxxxx
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-Chia Lee Division of Nephrology
- 楊皇煜 Division of Nephrology
- Ya-Chung Tian Division of Nephrology
- Wen-Hung Huang Division of Nephrology
- HSIANG-HAO HSU Division of Nephrology
- 涂昆樺 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chih-Jen Wu Division of Nephrology
- 潘吉豐 Division of Nephrology
- 施宏謀 Division of Nephrology
- 林承叡 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHENG-HSU CHEN Division of Nephrology
- 蔡尚峰 Division of Nephrology
- TUNG-MIN YU Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
428 participants
